XERIS BIOPHARMA HOLDINGS INC (XERS) Stock News
NASDAQ:XERS - Nasdaq - US98422E1038 - Common Stock - Currency: USD
XERS Latest News, Press Relases and Analysis
Would Mark Minervini consider XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) a top stock pick?
Why the high growth investor may take a look at XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS). A fundamental and technical analysis of (NASDAQ:XERS).
Is Personalis, Inc. (PSNL) the Best Multibagger Penny Stock to Buy According to Billionaires?
We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Personalis, Inc. (NASDAQ:PSNL) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks always seem like bargains for gaining exposure to some of […]
Is Fubotv Inc. (FUBO) the Best Multibagger Penny Stock to Buy According to Billionaires?
We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Fubotv Inc. (NYSE:FUBO) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks always seem like bargains for gaining exposure to some of […]
Is CommScope Holding Company, Inc. (COMM) the Best Multibagger Penny Stock to Buy According to Billionaires?
We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are going to take a look at where CommScope Holding Company, Inc. (NASDAQ:COMM) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks always seem like bargains for gaining exposure to […]
Is Lumen Technologies, Inc. (LUMN) the Best Multibagger Penny Stock to Buy According to Billionaires?
We recently published a list of 10 Best Multibagger Penny Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Lumen Technologies, Inc. (NYSE:LUMN) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks always seem like bargains for gaining exposure to some […]
Jim Cramer on CVS Health (CVS): “CVS Is the Best… the Last One Standing”
We recently published a list of Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks. In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer […]
GraniteShares Launches New Leveraged, Single-Stock EV ETFs
- GraniteShares just introduced two leveraged single-stock ETFs. - The new ETFs are focused on EV-makers Lucid Group and Rivian Automotive. - The expense ratio is 1.15% for both funds.
Jim Cramer on Shopify (SHOP): “De Minimis Will Sort Itself Out”
We recently published a list of Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks. In this article, we are going to take a look at where Shopify Inc. (NASDAQ:SHOP) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed […]
Jim Cramer on CSX Corp (CSX): “There Is an Element of Forgiveness Today”
We recently published a list of Jim Cramer Reveals Where Investors Fled During Tariff Selloff & Discusses 10 Stocks. In this article, we are going to take a look at where CSX Corporation (NASDAQ:CSX) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed […]
Plug Power Inc. (PLUG): Among EV Penny Stock From $10 to Under $1
We recently published a list of EV Penny Stocks List: From $10 to Under $1. In this article, we are going to take a look at where Plug Power Inc. (NASDAQ:PLUG) stands against other stocks in EV penny list: from $10 to under $1. The global electric vehicle (EV) market is on a roll despite […]
3 No-Brainer EV Stocks to Buy With $100 Right Now
ChargePoint, Nio, and Archer Aviation are high-risk, high-reward plays.
NVIDIA Corporation (NVDA): Among Stocks That Could 10X Over the Next 2 Years
We recently published a list of 9 Stocks That Could 10X Over the Next 2 Years. In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against other stocks that could 10X over the next 2 years. US Tariffs and the Stock Market Turmoil While tariffs from the US […]
Bright Peak Therapeutics Appoints John Schmid to its Board of Directors
Xeris Announces Changes to Its Board of Directors
Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid
Xeris Biopharma Stock Soars To Nearly 4-Year High On Strong 2025 Outlook, Retail Bulls Charge In
The company expects full-year revenue of $255 million to $275 million, significantly higher than the $239.77 million analysts had expected.
Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results; and Announces 2025 Guidance
Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025
Xeris Appoints Anh Nguyen, MD, MBA as Chief Medical Officer
Xeris to Participate in Upcoming Investor Conferences
The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness
/PRNewswire/ -- The American Diabetes Association® (ADA) and Xeris Pharmaceuticals® (Xeris BioPharma Holdings, Inc.), a national supporter of the ADA, are...
Xeris Expects to Exceed Full-Year 2024 Financial Guidance
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference
Xeris Biopharma Reports Third Quarter 2024 Financial Results
Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Xeris to Participate in Upcoming Investor Conferences
XERS Stock Earnings: Xeris Biopharma Holdings Beats EPS, Beats Revenue for Q2 2024
XERS stock results show that Xeris Biopharma Holdings beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
XERS Stock Earnings: Xeris Biopharma Holdings Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Xeris Biopharma Holdings (NASDAQ:XERS) just reported results for the second qua...
